|
|
||||||||
From The Biological Laboratories, Harvard University, Cambridge, Massachusetts 02138 and the Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Abstract
The action of C3bINA and
1H on cell-bound C3b is described in this paper. The
-polypeptide of C3b that binds covalently to cell surfaces is cleaved by the C3bINA and
1H into two fragments: one of 60,000 (C3b
-60) and another of 40,000 (C3b
-40) daltons. The
-chain of C3b is unaffected by the C3bINA and
1H. The three polypeptides, C3b
-60, C3b
-40, and C3
, are held together as a single unit by disulfide bonds. This unit, referred to as C3b', is covalently bound to cell surfaces via the C3b
-60 polypeptide. The conversion of C3b to C3b' by C3bINA and
1H abolishes the ability of the C3b-bearing cells to adhere to human erythrocytes as well as the ability to form, on the cell surface, the B, &D, and properdin-dependent amplification C3-convertase. However, the agglutinability of the cells with either anti-C3c or anti-C3d is not affected.
Treatment of the C3b'-bearing cells with trypsin releases fragments of C3b' into solution, leaving a polypeptide of 32,000 daltons covalently linked to the membrane. Since the trypsinized cells are agglutinable by anti-C3d but not by anti-C3c, the 32,000 dalton polypeptide appears to correspond antigenically to C3d.
Footnotes
1 This work was supported by a grant from The American Cancer Society (IM-164) and from The National Science Foundation Program in Human Cell Biology (PCM 77-10206).
2 Present address: Department of Genetics, School of Medicine, Washington University, St. Louis, Missouri 63110.
3 Research Career Development Awardee (AI-02245).
This article has been cited by other articles:
![]() |
C. Kemper, P. F. Zipfel, and I. Gigli The Complement Cofactor Protein (SBP1) from the Barred Sand Bass (Paralabrax nebulifer) Mediates Overlapping Regulatory Activities of Both Human C4b Binding Protein and Factor H J. Biol. Chem., July 31, 1998; 273(31): 19398 - 19404. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |